Summary of the practice guideline 'Diabetes mellitus type 2' (first revision) of the Dutch College of General Practitioners
Abstract
The main changes of the first revision of the guideline of the Dutch College of General Practitioners on the diagnosis and treatment of diabetes mellitus type 2 compared with the first edition concern the following aspects: more attention is given to organisation and management of diabetes care; new diagnostic criteria for diabetes are introduced; guidelines are given for the early detection of diabetes in high risk groups; the distinction between sulfonylureas of the first and the second generation has been dropped; in the treatment of patients with diabetes and a body mass index > 27 metformin is the drug of first choice; optional guidelines are given for the treatment with insulin; guidelines are given for the treatment of hypertension and hypercholesterolaemia in patients with diabetes.
Read the paper
Related studies
- Metformin as an adjuvant in breast cancer treatment
- Metformin Lysosomal Targeting: A Novel Aspect to Be Investigated for Metformin Repurposing in Neurodegenerative Diseases?
- Aberrant HSF1 signaling activation underlies metformin amelioration of myocardial infarction in mice
- Metformin induces ZFP36 by mTORC1 inhibition in cervical cancer-derived cell lines
- Protein Interaction Network for Identifying Vascular Response of Metformin (Oral Antidiabetic)
- Preventing Long COVID With Metformin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.